Head Spinal Program, Toronto Western Hospital
About Michael G. Fehlings, MD, PhD, FRCSC, FACS
Dr. Fehlings is the Medical Director of the Krembil Neuroscience Center and heads the Spinal Program at the Toronto Western Hospital. Dr. Fehlings is a Professor of Neurosurgery at the University of Toronto, holds the Halbert Chair in Neural Repair and Regeneration, a Scientist at the McEwen Centre for Regenerative Medicine, and a McLaughlin Scholar in Molecular Medicine. In the fall of 2008, Dr. Fehlings was appointed the inaugural Director of the University of Toronto Neuroscience Program and Co-Director of the newly formed University of Toronto Spinal Program. In 2014, he was elected as a Fellow of both the Royal Society of Canada and the Canadian Academy of Health Sciences.
Dr. Fehlings combines an active clinical practice in complex spinal surgery with a translationally oriented research program focused on discovering novel treatments for spinal cord injury. This is reflected by the publication of over 300 peer-reviewed articles chiefly in the area of spinal cord injury and complex spinal surgery. Dr. Fehlings leads a multi-disciplinary team of researchers, which is examining the application of stem cells, nanotechnology and tissue engineering for spinal cord repair and regeneration. He is also a principal investigator in the Christopher and Dana Reeve Foundation North American Clinical Trials Network, is co-chair of the internationally renowned Spine Trauma Study Group and leads several international clinical research efforts through AOSpine.
Dr. Michael Fehlings has received numerous prestigious awards including the Gold Medal in Surgery from the Royal College of Physicians and Surgeons (1996), nomination to the Who's Who list of the 1000 most influential scientists of the 21st century (2001), the Lister Award in Surgical Research (2006), the Leon Wiltse Award from the North American Spine Society for excellence in leadership and/or clinical research in spine care (2009), and the Olivecrona Award (2009) from the Karolinska Institute in Stockholm, Sweden (known as the "Nobel Prize of Neuroscience") for his important contributions in spinal cord injury.
In 2012, he received the Reeve-Irvine research medal for spinal cord injury. In 2013, he was again honored by the North American Spine Society with the Henry Farfan Award for outstanding contributions in spine related basic science research. He was also honored, in 2013, to receive the H. Richard Winn Award from the Society of Neurological Surgeons, which is the highest honor for academic neurosurgeons in North America.
Dr. Fehlings is active in many medical societies and journal editorial boards, including Journal of Neurosurgery (Past-Chairman Editorial Board) and Journal of Neurotrauma and Spine where he holds the position of Deputy Editor. His commitment to patients with neurotrauma is further reflected in his volunteer work for ThinkFirst, a charitable organization that is focused on preventing brain and spinal cord injuries in children.
- Professor of Neurosurgery, University of Toronto
- Halbert Chair in Neural Repair and Regeneration
- McLaughlin Scholar in Molecular Medicine
- Director, University of Toronto Neuroscience Program
- Co-Director, University of Toronto Spinal Program
- Medical Director, Krembil Neuroscience Center
- Head, Spine and Spinal Cord Injury Program
- Toronto Western Hospital, University Health Network
To see a full list of Dr. Fehlings' publications, please visit his PubMed listing.
Articles Written by Michael G. Fehlings, MD, PhD, FRCSC, FACS
Case Studies Presented by Michael G. Fehlings, MD, PhD, FRCSC, FACS
Articles Reviewed by Michael G. Fehlings, MD, PhD, FRCSC, FACS
SpineUniverse, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.
To help achieve this goal, SpineUniverse requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.
The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.